Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth (APEXMTA)
Primary Purpose
Dental Pulp Necrosis
Status
Completed
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Mineral Trioxide Aggregate
Calcium hydroxide
Sponsored by
About this trial
This is an interventional treatment trial for Dental Pulp Necrosis focused on measuring Apexification, Pulp necrosis, Calcium hydroxide, MTA, pulp necrosis of an anterior immature tooth
Eligibility Criteria
Inclusion Criteria:
- Indication of apexification treatment of an anterior immature tooth
- Patients aged 6 to 18
- Enlightened agreement of the patient and his/her legal representatives
- Prerequisite medical examination
Exclusion Criteria:
General disease
- diabetes
- immunosuppression of whatever origin (AIDS, drugs, …)
- severe asthma
- chronical disease requiring treatment
- eating disorders (anorexia, bulimia, malnutrition, …) Oral disease
- periodontal disease
- Administration of corticoids in a period of 3 months preceding the inclusion
- Patient with no social security cover
Sites / Locations
- Hôpital Bretonneau
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Calcium hydroxide
MTA
Arm Description
Outcomes
Primary Outcome Measures
Main success criterion: presence of a calcified apical barrier or not at 3, 6 and 12 months
Secondary Outcome Measures
Additional criterions :- presence of clinical symptoms or not- apical morphology - depth of this apical barrier At 3, 6 and 12 months
Full Information
NCT ID
NCT00472173
First Posted
May 10, 2007
Last Updated
November 9, 2011
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT00472173
Brief Title
Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth
Acronym
APEXMTA
Official Title
Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth
Study Type
Interventional
2. Study Status
Record Verification Date
November 2011
Overall Recruitment Status
Completed
Study Start Date
May 2007 (undefined)
Primary Completion Date
November 2010 (Actual)
Study Completion Date
May 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Pulp necrosis is one of the main complication of dental trauma. When it happens on an immature tooth, pulp necrosis implies a lack of root maturation and apical closure. A therapy called apexification is required to induce the formation of a calcified apical barrier allowing a permanent and hermetic root filling.The aim of this study is to compare the efficacy of a new apexification method using Mineral Trioxide Aggregate (MTA®) with the reference treatment based on calcium hydroxide repeated stimulations.
Detailed Description
36 patients aged 6 to 18 and presenting a non vital immature tooth will be included in the study (inclusion period: 12 months). These patients will be randomly divided into two groups: one treated with MTA®, and the other one with calcium hydroxide. For each patient, the total duration of the study will be 12 months. Recalls will be performed at 15 and 21 days and then at 3, 6 and 12 months to assess by clinical and X-ray exams the main success criterion: presence of a calcified apical barrier or not. Additional criterions such as presence of clinical symptoms or not, apical morphology and depth of this apical barrier will be observed. This randomised prospective therapeutic study will allow to assess the ability of MTA® inducing apexification of a non vital immature tooth. Furthermore, it will be possible to compare for both materials the kinetics of clinical symptoms disappearance and the morphology and depth of apices.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Pulp Necrosis
Keywords
Apexification, Pulp necrosis, Calcium hydroxide, MTA, pulp necrosis of an anterior immature tooth
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Calcium hydroxide
Arm Type
Active Comparator
Arm Title
MTA
Arm Type
Experimental
Intervention Type
Drug
Intervention Name(s)
Mineral Trioxide Aggregate
Intervention Description
Apexification treatment of the tooth with Mineral Trioxide Aggregate
Intervention Type
Drug
Intervention Name(s)
Calcium hydroxide
Intervention Description
Apexification treatment of the tooth with Calcium hydroxide
Primary Outcome Measure Information:
Title
Main success criterion: presence of a calcified apical barrier or not at 3, 6 and 12 months
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Additional criterions :- presence of clinical symptoms or not- apical morphology - depth of this apical barrier At 3, 6 and 12 months
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Indication of apexification treatment of an anterior immature tooth
Patients aged 6 to 18
Enlightened agreement of the patient and his/her legal representatives
Prerequisite medical examination
Exclusion Criteria:
General disease
diabetes
immunosuppression of whatever origin (AIDS, drugs, …)
severe asthma
chronical disease requiring treatment
eating disorders (anorexia, bulimia, malnutrition, …) Oral disease
periodontal disease
Administration of corticoids in a period of 3 months preceding the inclusion
Patient with no social security cover
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Jacques Lasfargues, Dentist PhD
Organizational Affiliation
Hôpital Bretonneau - Paris
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Raphaël SERREAU, MD, PhD
Organizational Affiliation
URC Paris Centre
Official's Role
Study Director
Facility Information:
Facility Name
Hôpital Bretonneau
City
Paris
ZIP/Postal Code
75018
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
21752247
Citation
Beslot-Neveu A, Bonte E, Baune B, Serreau R, Aissat F, Quinquis L, Grabar S, Lasfargues JJ. Mineral trioxyde aggregate versus calcium hydroxide in apexification of non vital immature teeth: study protocol for a randomized controlled trial. Trials. 2011 Jul 13;12:174. doi: 10.1186/1745-6215-12-174.
Results Reference
derived
Learn more about this trial
Assessment of a New Apexification Method for Patients Presenting a Non Vital Immature Tooth
We'll reach out to this number within 24 hrs